Inactive Instrument
Enzymatica AB Stock Nasdaq Stockholm
Stocks
SE0003943620
Pharmaceuticals
OTC Markets Traded| Market Cap | 432M 384M 359M 325M 614M 41.65B 619M 4.31B 1.68B 21.25B 1.62B 1.59B 68.31B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 400M 355M 332M 301M 569M 38.56B 573M 3.99B 1.55B 19.67B 1.5B 1.47B 63.23B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.32% | +3.00% | - | - | 43.02M | |
| +1.27% | -1.99% | +37.39% | +105.41% | 1,019B | |
| +0.87% | -4.54% | +35.74% | +62.02% | 610B | |
| +0.51% | +1.35% | +15.93% | +80.01% | 470B | |
| +1.37% | -5.30% | +59.19% | +36.08% | 344B | |
| +0.26% | +0.14% | +21.29% | +40.99% | 336B | |
| +0.60% | -3.09% | +10.76% | +32.59% | 266B | |
| +1.65% | -3.78% | -6.03% | +9.29% | 241B | |
| -0.24% | -5.06% | +36.75% | +50.37% | 218B | |
| -0.53% | -4.90% | +26.66% | +92.49% | 179B | |
| Average | +0.79% | -3.63% | +26.41% | +56.58% | 409.2B | |
| Weighted average by Cap. | +0.82% | -3.51% | +29.62% | +67.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.46M 37.86M 34.32M 64.81M 4.39B 65.28M 455M 177M 2.24B 171M 167M 7.21B | 53.9M 47.85M 44.78M 40.59M 76.65M 5.2B 77.21M 538M 209M 2.65B 202M 198M 8.52B |
| Net income | -53.18M -47.21M -44.18M -40.04M -75.62M -5.13B -76.17M -531M -206M -2.62B -200M -195M -8.41B | -51.89M -46.06M -43.11M -39.07M -73.79M -5B -74.32M -518M -201M -2.55B -195M -191M -8.2B |
| Net Debt | -73.01M -64.81M -60.65M -54.97M -104M -7.04B -105M -728M -283M -3.59B -274M -268M -11.54B | -32.11M -28.5M -26.68M -24.18M -45.66M -3.1B -45.99M -320M -125M -1.58B -121M -118M -5.08B |
Employees
-
Sector
Pharmaceuticals
Calendar
